MannKind Corp MNKD

Healthcare Biotechnology

MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. Its products include Afrezza (insulin human) Inhalation Powder and the V-Go wearable insulin delivery device. The Afrezza (insulin human) Inhalation Powder is an inhaled insulin indicated to enhance glycemic control in adults with diabetes. The V-Go wearable insulin delivery device provides subcutaneous infusion of insulin in adults that require insulin. Its orphan lung disease pipeline includes Tyvaso DPI (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

NDAQ:MNKD - Post by User

MannKind Corp

Bullboard Posts

Comment by Firebag3on Jun 09, 2014 3:14pm

360 Views

Post# 22643133

RE:Purchased a small position.

Hello one and all
Since my original post 16-Feb-2014 I am closing in on a double. IF/ WHEN FDA approves this application, I / WE will be in for one very enjoyable ride..

Bullboard Posts

This junior mining stock offers billions in market exposure